WITH RECORD CUSTOMER GROWTH, GENXYS SUPPORTS RIGHT DRUG DOSE NOW ACT TO REDUCE ADVERSE DRUG REACTIONS THROUGH PRECISION MEDICINE

0
256

Pharmacogenetic Testing & EHR Integration Help Avoid Trial-and-Error Prescribing

GenXys Health Care Systems

VANCOUVER, Canada, April 21, 2022 GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, added a record five pharmacogenetic companies as customers in the first quarter of 2022. The unprecedented growth advanced GenXys’ support of reducing adverse drug events through the Right Drug Dose Now Act, legislation currently making its way through Congress.

97% of people have at least one pharmacogenetic variant that influences how medication is metabolized by the body.

The co-chairs of Congress’ Personalized Medicine Caucus, Representatives Eric Swalwell (D-CA) and Tom Emmer (R-MN), brought forth the legislation to address the prevalence of adverse drug events and advance the clinical adoption of pharmacogenetics (PGx)….

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here